Product Name | MF | CAS | Details |
---|
CER11-2′S(d9) | C34H69NO4 | 2260670-22-0 | Details |
Anti-GATB antibody produced in rabbit | Details |
PrEST Antigen DEPDC1B | Details |
Apolipoprotein E4 human | Details |
CIS-N-BENZYLHEXAHYDROPHTHALAMIC ACID | C15H19NO3 | 194874-82-3 | Details |
Anti-SOX21 antibody produced in rabbit | Details |
Methyl 3-(4-hydroxyphenyl)acrylate | C10H10O3 | 19367-38-5 | Details |
1,2-Dioleoyl-sn-glycero-3-phosphocholine | C44H84NO8P | 4235-95-4 | Details |
Anti-ZNF106 antibody produced in rabbit | Details |
3-Piperidin-3-ylpropan-1-ol | C8H17NO | 25175-58-0 | Details |
Monoclonal Anti-TEF1 antibody produced in mouse | Details |
2-Chloro-6-methylpyridine | C6H6ClN | 18368-63-3 | Details |
6,16-DIMETHYL-16-DEHYDROPREGNENOLONE ACETATE | C25H36O3 | 29147-79-3 | Details |
[4-(1-Piperidinylmethyl)-1H-pyrazol-1-yl]acetic acid | C11H17N3O2 | 1264100-89-1 | Details |
11,12-DIMETHYL-1,21-DOCOSADIENE-11,12-DIOL | C24H46O2 | 1053659-44-1 | Details |
N-(2-(2-(4-(BENZYLOXY)BENZYLIDENE)HYDRAZINO)-2-OXOETHYL)-2-IODOBENZAMIDE | C23H20IN3O3 | 769148-76-7 | Details |
Anti-RNF219 antibody produced in rabbit | Details |
Trimethyl orthovalerate | C8H18O3 | 13820-09-2 | Details |
N'-{(E)-[3-(BENZYLOXY)PHENYL]METHYLIDENE}-2-[(4,5-DIPHENYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETOHYDRAZIDE | C30H25N5O2S | 306756-09-2 | Details |
Phosphatase Inhibitor Cocktail Set V, 50X | Details |
N-(1,3-BENZODIOXOL-5-YL)-2-[(3-ETHYL-5,6-DIMETHYL-4-OXO-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETAMIDE | C19H19N3O4S2 | 618427-56-8 | Details |
4-(4-Chlorophenyl)benzoic acid | C13H9ClO2 | 5748-41-4 | Details |
4-Chlorobenzoic acid-(phenyl-13C6) | C7H5ClO2 | 1173019-28-7 | Details |
2'-HYDROXY-4',6'-DIMETHYLACETOPHENONE | C10H12O2 | 16108-50-2 | Details |
2-(6-BROMO-4-OXO-3(4H)-QUINAZOLINYL)-N-(2-ETHOXYPHENYL)ACETAMIDE | C18H16BrN3O3 | 883823-65-2 | Details |
Pipette Stand | Details |
RCL T175641 | Details |
N'-(2,5-DIMETHOXYBENZYLIDENE)BENZOHYDRAZIDE | 325809-38-9 | Details |
Z-Phe-Bt | C23H20N4O3 | 769922-77-2 | Details |
RCL R553336 | C18H20N2O2 | 326021-49-2 | Details |
p-Toluenesulfonyl fluoride | C7H7FO2S | 455-16-3 | Details |
ethyl 8-ethoxy[1,3]dioxolo[4,5-g]quinoline-7-carboxylate | C15H15NO5 | 33331-61-2 | Details |
Anti-Phospho-ERK1-T202 + ERK2-T185 antibody produced in rabbit | Details |
PrEST Antigen OAZ1 | Details |
N,N-diallyl-2-phenylacetamide | C14H17NO | 39109-16-5 | Details |
Ammonium formate solution | CH5NO2 | 540-69-2 | Details |
2,6-BIS-(4-MEO-PHENYL)-4-OXO-CYCLOHEXANE-1,1-DICARBOXYLIC ACID DIMETHYL ESTER | C24H26O7 | 41167-39-9 | Details |
1-{2-METHYL-1-[(PHENYLSULFANYL)METHYL]PROPYL}VINYL PHENYL SULFONE | 1053658-94-8 | Details |
9-(2-(N-METHYLCARBAMOYL)BENZYL)XANTHEN-9-OL | 200280-74-6 | Details |
TETRAKIS(TRIPHENYLSILYL)TIN | 200561-52-0 | Details |
RCL T214590 | 75725-38-1 | Details |
LP 12 hydrochloride hydrate | C32H40ClN3O | 1185136-22-4 | Details |
Tellurium Standard for ICP | H2Te | Details |
Mant-GTP triethylammonium salt solution | 148821-03-8 | Details |
4-Butylbenzonitrile | C11H13N | 20651-73-4 | Details |
2-PHENYL-N-(2,2,2-TRICHLORO-1-(3-NITROANILINO)ETHYL)ACETAMIDE | C16H14Cl3N3O3 | 301816-66-0 | Details |
Anti-Nerve Growth Factor Receptor (NGFR p75) antibody produced in rabbit | Details |
Allylmalonic acid | C6H8O4 | 2583-25-7 | Details |
Trimethyl chitosan | 52349-26-5 | Details |
ETHYL 4-AMINO-2,6-DIOXO-1,2,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE | C8H10N2O4 | 17325-36-9 | Details |
Anti-p15 INK antibody produced in rabbit | Details |
4-Pentylphenol | C11H16O | 14938-35-3 | Details |
Anti-ACTL8 antibody produced in mouse | Details |
1-BUTYL-3-(4-ISOPROPYLPHENYL)-2-THIOUREA | C14H22N2S | 195523-88-7 | Details |
9-CHLORO-2-(4-METHOXYPHENYL)-1'-METHYL-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,4'-PIPERIDINE] | C22H24ClN3O2 | 786674-04-2 | Details |
4-(Diphenylhydroxymethyl)benzoic acid | C20H16O3 | 19672-49-2 | Details |
2,2,2-TRIFLUORO-N-(2-OXO-3-((TRIFLUOROACETYL)AMINO)PROPYL)ACETAMIDE | C7H6F6N2O3 | 1869-29-0 | Details |
2-METHYL-3-M-TOLYL-ACRYLIC ACID | C11H12O2 | 849831-35-2 | Details |
2-((2E)-2-{2-[(4-BROMOBENZYL)OXY]BENZYLIDENE}HYDRAZINO)-N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-OXOACETAMIDE | C25H21BrN4O3S | 880018-00-8 | Details |
Anti-Integrin αVβ5 Antibody, clone P1F6, FITC conjugated | Details |
2-BENZYLSELANYL-1H-BENZOIMIDAZOLE | 478912-01-5 | Details |
6-CL-3-(2,3-DIOXO-3-(4-TOLUIDINO)PR)N-(2-METHOXYPHENYL)-2-QUINOXALINECARBOXAMIDE | 919704-25-9 | Details |
ONIX2 PREMIXED GAS REGULATOR | Details |
N-Boc-cadaverine | C10H22N2O2 | 51644-96-3 | Details |
Anti-INCA1 antibody produced in rabbit | Details |
Anti-FKBP8 antibody produced in mouse | Details |
Atomoxetine hydrochloride solution | C17H22ClNO | 82248-59-7 | Details |
2-{(5Z)-5-[1-(CARBOXYMETHYL)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE]-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL}PROPANOIC ACID | C16H12N2O6S2 | 372507-43-2 | Details |
Anti-PRELID1 antibody produced in rabbit | Details |
3-HYDROXY-4-P-TOLYLAZO-NAPHTHALENE-2-CARBOXYLIC ACID (2-METHOXY-PHENYL)-AMIDE | C25H21N3O3 | 883805-62-7 | Details |
Certified polypropylene caps with septa, pkg of 100 | Details |
N'-(5-BROMO-2-HYDROXYBENZYLIDENE)-2-(4-BUTOXYPHENOXY)ACETOHYDRAZIDE | C19H21BrN2O4 | 351878-68-7 | Details |
4-(METHOXYCARBONYL)PHENYL N-(4-(METHYLTHIO)PHENYL)CARBAMATE | 199435-65-9 | Details |
Anti-Phospho-HDAC5-S498 antibody produced in rabbit | Details |
3-BETA-HYDROXYANDROST-5-ENE-17-BETA-CARBOXYLIC ACID HYDRAZIDE | C20H32N2O2 | Details |
3-(2-phenylethyl)-1,3-benzothiazol-2(3H)-one | C15H13NOS | 142224-24-6 | Details |
Syringaldehyde | C9H10O4 | 134-96-3 | Details |
METHYL 3ALPHA-HYDROXYETIOCHOLANATE | Details |
1-(3,5-DICHLOROPHENYL)-3-(3-NITROPHENYL)UREA | 197799-29-4 | Details |
Feline Adipocyte Differentiation Medium (250 ml) | Details |
Anti-DNA G-quadruplex (G4) Antibody, clone 1H6 ZooMAb? Mouse Monoclonal | Details |
4-(2,6-Dimethylphenoxy)butanoic acid | C12H16O3 | 853743-95-0 | Details |
2-[(Phenylsulfonyl)methyl]benzyl bromide | C14H13BrO2S | 88116-02-3 | Details |
Anti-PRAME antibody produced in rabbit | Details |
Anti-WSB2 antibody produced in rabbit | Details |
5-((2-CHLOROBENZYL)THIO)-1,3,4-THIADIAZOL-2-YL HYDROSULFIDE | C9H7ClN2S3 | 345991-75-5 | Details |
pyrimidine-5-carboxaldehyde | C5H4N2O | 10070-92-5 | Details |
4-HO-N'-(4-HO-3-MEO-BENZYLIDENE)-2-OXO-1-PENTYL-1,2-2H-3-QUINOLINECARBOHYDRAZIDE | C23H25N3O5 | 376606-53-0 | Details |
Rosetta(DE3)pLysS Competent Cells - Novagen | Details |
2-[(1,3-BENZODIOXOL-5-YLMETHYL)AMINO]-3-{(Z)-[3-(2-METHOXYETHYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}-9-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C24H22N4O5S2 | 618076-72-5 | Details |
GMP100 MIXING HEAD RETROFIT EP | Details |
Anti-phospho-ILK (Ser246) Antibody | Details |
3-(3-CHLORO-4-METHYLPHENYL)-1,1-DIPROPYLUREA | C14H21ClN2O | 67759-56-2 | Details |
Anti-RC3H2 antibody produced in rabbit | Details |
H-Lys(Z)-OH | C14H20N2O4 | 1155-64-2 | Details |
N,N-DIBUTYL-4-(2,5-DICHLOROPHENYLAZO)-3,5-XYLIDINE | C22H29Cl2N3 | 198066-50-1 | Details |
DIISOPROPYL (1S,10BR)-3-(4-BROMOBENZOYL)-1,10B-DIHYDROPYRROLO(2,1-A)PHTHALAZINE-1,2-DICARBOXYLATE | C26H25BrN2O5 | 853349-11-8 | Details |
2-Chlorobenzenesulfonyl chloride | C6H4Cl2O2S | 2905-23-9 | Details |
4-(4-CL-PH)-2-ME-6-OXO-1,4,5,6-TETRAHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER | C15H16ClNO3 | 329700-15-4 | Details |
2-AMINO-1-(3-CYANO-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIEN-2-YL)-7,7-DIMETHYL-5-OXO-4-(3-PYRIDINYL)-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBONITRILE | C27H27N5OS | 309720-07-8 | Details |
Product Total: Product Page: | ||||
501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 |